首页> 美国卫生研究院文献>Cell Death Disease >Synergistic induction of cell death in liver tumor cells by TRAIL and chemotherapeutic drugs via the BH3-only proteins Bim and Bid
【2h】

Synergistic induction of cell death in liver tumor cells by TRAIL and chemotherapeutic drugs via the BH3-only proteins Bim and Bid

机译:TRAIL和化学治疗药物通过仅BH3蛋白Bim和Bid协同诱导肝肿瘤细胞死亡

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although death receptors and chemotherapeutic drugs activate distinct apoptosis signaling cascades, crosstalk between the extrinsic and intrinsic apoptosis pathway has been recognized as an important amplification mechanism. Best known in this regard is the amplification of the Fas (CD95) signal in hepatocytes via caspase 8-mediated cleavage of Bid and activation of the mitochondrial apoptosis pathway. Recent evidence, however, indicates that activation of other BH3-only proteins may also be critical for the crosstalk between death receptors and mitochondrial triggers. In this study, we show that TNF-related apoptosis-inducing ligand (TRAIL) and chemotherapeutic drugs synergistically induce apoptosis in various transformed and untransformed liver-derived cell lines, as well as in primary human hepatocytes. Both, preincubation with TRAIL as well as chemotherapeutic drugs could sensitize cells for apoptosis induction by the other respective trigger. TRAIL induced a strong and long lasting activation of Jun kinase, and activation of the BH3-only protein Bim. Consequently, synergistic induction of apoptosis by TRAIL and chemotherapeutic drugs was dependent on Jun kinase activity, and expression of Bim and Bid. These findings confirm a previously defined role of TRAIL and Bim in the regulation of hepatocyte apoptosis, and demonstrate that the TRAIL–Jun kinase–Bim axis is a major and important apoptosis amplification pathway in primary hepatocytes and liver tumor cells.
机译:尽管死亡受体和化学治疗药物激活不同的凋亡信号传导级联,但外在和内在凋亡途径之间的串扰已被认为是重要的扩增机制。在这方面最著名的是通过半胱天冬酶8介导的Bid切割和线粒体凋亡途径的活化在肝细胞中的Fas(CD95)信号的扩增。然而,最近的证据表明,其他仅BH3的蛋白质的激活对于死亡受体和线粒体触发物之间的串扰也可能至关重要。在这项研究中,我们表明TNF相关凋亡诱导配体(TRAIL)和化学治疗药物在多种转化和未转化的肝源性细胞系以及原代人肝细胞中协同诱导凋亡。与TRAIL一起预温育以及化学治疗药物均可以使细胞通过其他各自的触发物诱导细胞凋亡。 TRAIL诱导了Jun激酶的强而持久的激活,以及仅BH3蛋白Bim的激活。因此,TRAIL和化疗药物协同诱导的凋亡依赖于Jun激酶的活性以及Bim和Bid的表达。这些发现证实了TRAIL和Bim在肝细胞凋亡调控中的先前定义的作用,并证明TRAIL–Jun激酶–Bim轴是原代肝细胞和肝肿瘤细胞中主要且重要的凋亡扩增途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号